Form 4: GE HealthCare Technologies Inc. Executive Sells Shares
SEC Form 4 Filing
Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., sold 900 shares of common stock on November 5, 2024.
Summary
- On November 5, 2024, Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., sold 900 shares of the company's common stock.
- The shares were sold at a weighted average price of $87.63, with individual transactions ranging from $87.63 to $87.66.
- Following the transaction, Rackliffe directly owns 12,715 shares of GE HealthCare Technologies Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive. It doesn't inherently convey positive or negative sentiment, but the market may interpret executive sales in light of other information.
Industry Context
Executive stock sales are a common occurrence and are often scrutinized by investors for insights into management's perspective on the company's future prospects. However, without additional context, it's difficult to determine the specific reasons behind this sale.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders, depending on how the market interprets the transaction.
Key Dates
| Date | Description |
|---|---|
| 11/05/2024 | Date of the stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.